Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents

• Status: Completed
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: All

Summary

A study of the safety and pharmacokinetics of solithromycin capsules in adolescents

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cempra Inc; Melinta Therapeutics, Inc.
• Collaborator: Department of Health and Human Services
• Treatments: Solithromycin

Criteria

Inclusion Criteria:

• 12 to 17 yo male or female with suspected or confirmed bacterial infection

Exclusion Criteria:

• Bacterial meningitis

• Clinical significant concomitant medical condition